BRAF mutations in chronic lymphocytic leukemia.
Jebaraj, Billy Michael Chelliah
BRAF mutations in chronic lymphocytic leukemia. [electronic resource] - Leukemia & lymphoma Jun 2013 - 1177-82 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1029-2403
10.3109/10428194.2012.742525 doi
Antineoplastic Agents--therapeutic use
Apoptosis--genetics
Exons
Extracellular Signal-Regulated MAP Kinases--metabolism
Humans
Indoles--therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Mitogen-Activated Protein Kinases--metabolism
Mutation
Niacinamide--analogs & derivatives
Phenylurea Compounds--therapeutic use
Phosphorylation
Protein Kinase Inhibitors--therapeutic use
Proto-Oncogene Proteins B-raf--genetics
Signal Transduction
Sorafenib
Sulfonamides--therapeutic use
Treatment Outcome
BRAF mutations in chronic lymphocytic leukemia. [electronic resource] - Leukemia & lymphoma Jun 2013 - 1177-82 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1029-2403
10.3109/10428194.2012.742525 doi
Antineoplastic Agents--therapeutic use
Apoptosis--genetics
Exons
Extracellular Signal-Regulated MAP Kinases--metabolism
Humans
Indoles--therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Mitogen-Activated Protein Kinases--metabolism
Mutation
Niacinamide--analogs & derivatives
Phenylurea Compounds--therapeutic use
Phosphorylation
Protein Kinase Inhibitors--therapeutic use
Proto-Oncogene Proteins B-raf--genetics
Signal Transduction
Sorafenib
Sulfonamides--therapeutic use
Treatment Outcome